Conversion from Cyclosporine to Tacrolimus Improves Quality-of-Life Indices, Renal Graft Function and Cardiovascular Risk Profile
Open Access
- 1 June 2004
- journal article
- clinical trial
- Published by Elsevier in American Journal of Transplantation
- Vol. 4 (6) , 937-945
- https://doi.org/10.1111/j.1600-6143.2004.00427.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients1Transplantation, 2003
- Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplantsBritish Journal of Surgery, 2000
- Progression of renal damage in chronic rejectionKidney International, 2000
- TGF-?? EXPRESSION IN RENAL TRANSPLANT BIOPSIESTransplantation, 2000
- NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVETransplantation, 1999
- Risk for posttransplant diabetes mellitus with current immunosuppressive medicationsAmerican Journal of Kidney Diseases, 1999
- Early graft function and patient survival following cadaveric renal transplantationKidney International, 1999
- Hyperlipidaemia in renal transplantation—risk factor for long‐term graft outcomeEuropean Journal of Clinical Investigation, 1995
- INCIDENCE, DETERMINANTS, AND CONSEQUENCES OF SUBCLINICAL NONCOMPLIANCE WITH IMMUNOSUPPRESSIVE THERAPY IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1995
- Illness cognition: Using common sense to understand treatment adherence and affect cognition interactionsCognitive Therapy and Research, 1992